United States - English - NLM (National Library of Medicine)

fondel chemicals ltd. - cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l) - cupric cation 0.4 kg in 1.6 kg - purpose: cupric sulphate pentahydrate powder is used as an aid in hoof rot management under veterinary guidance. - copper can be toxic to sheep. do not allow animals to eat or drink the cupric sulphate powder or hoof bath solution. - know the volume of the hoof bath and calculate the amount of cupric sulphate carefully. - do not overdose by using more cupric sulphate than what is recommended by your veterinarian.

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - cupric oxide (unii: v1xjq704r4) (cupric cation - unii:8cbv67279l) - cupric cation 3 [hp_x] in 1 g - directions: for oral use only. use: temporary relief of headache.

United States - English - NLM (National Library of Medicine)

fondel chemical ltd. - cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), citric acid (unii: 2968phw8qp) (carbon dioxide - unii:142m471b3j) - cupric cation 0.3 kg in 1.6 kg - - copper can be toxic to sheep. do not allow animals to eat or drink the acidified cupric sulfate powder or hoof bath solution. - know the volume of the hoof bath and calculate the amount of acidified cupric sulfate carefully. - do not over dose by using more acidified cupric sulfate than what is recommended by your veterinarian. purpose: acidified cupric sulfate powder is used as an aid in hoof rot management under veterinary guidance. use: acidified cupric sulfate powder is used in hoof baths for cattle and sheep.

United States - English - NLM (National Library of Medicine)

hospira, inc. - cupric chloride (unii: s2qg84156o) (cupric cation - unii:8cbv67279l) - cupric cation 0.4 mg in 1 ml - copper 0.4 mg/ml (cupric chloride injection, usp) is indicated for use as a supplement to intravenous solutions given for tpn. administration helps to maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. none known. none known.

United States - English - NLM (National Library of Medicine)

exela pharma sciences, llc - cupric chloride (unii: s2qg84156o) (cupric cation - unii:8cbv67279l) - cupric chloride injection, usp 0.4 mg/ml is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (tpn). administration helps to maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. none known. none known.

European Union - English - EMA (European Medicines Agency)

gmp-orphan sa - trientine tetrahydrochloride - hepatolenticular degeneration - other alimentary tract and metabolism products, - cuprior is indicated for the treatment of wilson's disease in adults, adolescents and children ≥ 5 years intolerant to d-penicillamine therapy.,

United States - English - NLM (National Library of Medicine)

bausch health us, llc - penicillamine (unii: gnn1dv99gx) (penicillamine - unii:gnn1dv99gx) - penicillamine 250 mg - cuprimine is indicated in the treatment of wilson's disease, cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy. available evidence suggests that cuprimine is not of value in ankylosing spondylitis. wilson's disease (hepatolenticular degeneration) occurs in individuals who have inherited an autosomal-recessive defect that leads to an accumulation of copper far in excess of metabolic requirements. the excess copper is deposited in several organs and tissues, and eventually produces pathological effects primarily in the liver, where damage progresses to postnecrotic cirrhosis, and in the brain, where degeneration is widespread. copper is also deposited as characteristic, asymptomatic, golden-brown kayser-fleischer rings in the corneas of all patients with cerebral symptomatology and some patients who are either asymptomatic or manifest only hepatic symptomatology. two types of patients require treatment for wilson's diseas

United States - English - NLM (National Library of Medicine)

sergeant's pet care products, inc. - cupric sulfate (unii: lrx7aj16dt) (copper - unii:789u1901c5) - cupric sulfate 6 mg in 1 ml

United States - English - NLM (National Library of Medicine)

homeocare laboratories - cupric arsenite (unii: sk8l60bcsq) (cupric cation - unii:8cbv67279l), copper (unii: 789u1901c5) (copper - unii:789u1901c5), potassium phosphate, dibasic (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9ffu82n), magnesium phosphate, tribasic, pentahydrate (unii: 453cof7817) (magnesium cation - unii:t6v3lhy838) - cupric cation 10 [hp_x] in 4.0 g - temporarily relieves muscle pains, spasms and cramps in calves, feet & legs. night cramps & pain of the lower limbs. temporarily relieves muscle pains, spasms and cramps in calves, feet & legs. night cramps & pain of the lower limbs.

United States - English - NLM (National Library of Medicine)

parke-davis div of pfizer inc - quinapril hydrochloride (unii: 33067b3n2m) (quinaprilat - unii:34ssx5lde5) - quinapril 5 mg - accupril is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with accupril. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pres